3306-62-5

Basic information

• Product Name: 2-Aminobenzenesulfonamide
• Synonyms: 2-amino-benzenesulfonamid;o-amino-benzenesulfonamid;o-aminobenzenesulfonamide;orthanilamide;o-sulfanilamide;o-Aminobenzenesulphonamide;2-AMINOBENZENESULFONAMIDE;2-AMINO-BENZENESULFONYL CHLORIDE
• CAS NO: 3306-62-5
• Molecular Formula: C₆H₈N₂O₂S
• Molecular Weight: 172.2
• EINECS: 221-988-1
• Product Categories: SULFONAMIDE;Intermediates of Dyes and Pigments;Sulphur Derivatives;Benzene derivates;Organic Building Blocks;Sulfonamides/Sulfinamides;Sulfur Compounds;Inhibitors
• Mol File: 3306-62-5.mol
• Article Data: 20

Chemical Properties

• Melting Point: 155-157 °C(lit.)
• Boiling Point: 392.7 °C at 760 mmHg
• Flash Point: 191.3 °C
• Appearance: white to pale cream crystalline powder or crystals
• Density: 1.3250 (rough estimate)
• Vapor Pressure: 2.25E-06mmHg at 25°C
• Refractive Index: 1.6490 (estimate)
• Storage Temp.: Keep in dark place,Inert atmosphere,Room temperature
• Solubility: DMSO (Sparingly), Methanol (Slightly)
• PKA: 10.29±0.60(Predicted)
• Water Solubility: 6.655g/L(24 oC)
• CAS DataBase Reference: 2-Aminobenzenesulfonamide(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Aminobenzenesulfonamide(3306-62-5)
• EPA Substance Registry System: 2-Aminobenzenesulfonamide(3306-62-5)

Safety Data

• Hazard Codes: Xi
• Statements: 36/37/38
• Safety Statements: 36/37/39-26-22-36
• WGK Germany: 3
• RTECS: DA9449000
• Hazardous Substances Data: 3306-62-5(Hazardous Substances Data)

Usage

Chemical Properties

white to pale cream crystalline powder or crystals

Uses

Diuretic;Inhibitor of carbonic anhydrase B

InChI:InChI=1/C6H8N2O2S/c7-5-3-1-2-4-6(5)11(8,9)10/h1-4H,7H2,(H2,8,9,10)

Upstream product

• 6961-82-6 2-chlorobenzenesulfonamide 
• 75304-18-6 N-acetyl-2-aminobenzenesulfonamide 
• 5661-14-3 N-(phenylsulfonyl)acetamide 
• 22057-44-9 1-(benzylsulfanyl)-2-nitrobenzene 
• 98-10-2 benzenesulfonamide 
• 72357-88-1 2-benzyl-2H-1,2,4-benzothiadiazin-3(4H)-one 1,1-dioxide 
• 62-53-3 aniline 
• 1694-92-4 2-Nitrobenzenesulfonyl chloride 
• 107342-23-4 2-(β-hydroxyethylamino)-5-nitrobenzenesulphonamide 
• 121-51-7 3-nitrobenzenesulphonyl chloride 
• 50881-48-6 N-chlorosulfonyl-N'-phenyl-urea 
• 13338-00-6 2H-1,2,4-benzothiadiazin-3(4H)-one 1,1-dioxide 
• 5455-59-4 2-Nitrobenzenesulfonamide 

Downstream Products

• 109899-55-0 N-(2-sulfamoyl-phenyl)-succinamic acid 
• 49738-46-7 2-benzoylamino-benzenesulfonamide 
• 6518-63-4 2-benzoylamino-benzenesulfonic acid benzoylamide 
• 90437-99-3 2-propionylamino-benzenesulfonic acid amide 
• 13338-00-6 2H-1,2,4-benzothiadiazin-3(4H)-one 1,1-dioxide 
• 90873-87-3 2-butyrylamino-benzenesulfonic acid amide 
• 4825-44-9 2-butyrylamino-benzenesulfonic acid butyrylamide 
• 359-85-3 2H-benzo[e][1,2,4]thiadiazine 1,1-dioxide 
• 98489-79-3 2-ethylamino-benzenesulfonic acid amide 
• 21639-28-1 2-methylaminobenzene sulfonamide 
• 98489-78-2 2-dimethylamino-benzenesulfonic acid amide 
• 88-21-1 2-amino-1-benzenesulfonic acid 
• 54734-84-8 2-amino-5-bromobenzenesulfonamide 
• 3306-82-9 3-(4-chlorophenyl)-3,4-dihydro-2H-1,2,4-benzothiadiazine-1,1-dioxide 

Relevant articles and documents

INHIBITORS OF PHOSPHOLIPID SYNTHESIS AND METHODS OF USE

Inhibitors of Glycerol 3-Phosphate Acyltransferase (GPAT) are provided; and methods of use in the treatment of cancer; and treatment of conditions relating to metabolic syndrome, hyperlipidemia, infection and inflammation.

Benzothiadiazine methoxy acrylate derivatives and preparation method and application thereof

The invention provides benzothiadiazine methoxy acrylate derivatives and a preparation method and application thereof, and the benzothiadiazine methoxy acrylate derivatives have the following chemicalstructural general formula VII as shown in the description, wherein R1 is hydrogen, fluorine, chlorine, bromine, iodine, methyl, ethyl, methoxy or nitro; and R2 is hydrogen, methyl or benzyl. According to the invention, an active group 3, 4-dihydro-2H-1, 2, 4-benzothiadiazine-1, 1-dioxo substitutes the side chain part of the methoxy acrylate bactericide and then is reasonably spliced with the pharmacophore of the methoxy acrylate bactericide, so that the bactericide with novel structure, broad spectrum, high efficiency and low toxicity is synthesized, the bactericide can be alternately used with the existing bactericide, the generation of resistance is avoided or delayed, the preparation conditions are conventional, the subsequent treatment is simple and convenient, and the industrialization is easy to realize.

MYELINATION STIMULATOR COMPOUNDS, AND METHODS OF TREATMENT

The invention is directed towards compounds, methods of stimulating myelination, stimulating proliferation of oligodendrocytes (OLs) or stimulating oligodendrocyte precursor cells and methods of treating diseases, disorders or symptoms thereof.